Chiron Capital Management’s Teladoc Health TDOC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $680K | Buy |
78,105
+12,600
| +19% | +$110K | 0.59% | 54 |
|
|
2025
Q1 | $521K | Buy |
65,505
+31,400
| +92% | +$250K | 0.47% | 54 |
|
|
2024
Q4 | $310K | Sell |
34,105
-32,297
| -49% | -$294K | 0.29% | 89 |
|
|
2024
Q3 | $610K | Buy |
66,402
+3,704
| +6% | +$34K | 0.54% | 48 |
|
|
2024
Q2 | $613K | Buy |
62,698
+29,198
| +87% | +$286K | 0.59% | 47 |
|
|
2024
Q1 | $506K | Buy |
33,500
+10,901
| +48% | +$165K | 0.46% | 58 |
|
|
2023
Q4 | $487K | Sell |
22,599
-4,999
| -18% | -$108K | 0.42% | 59 |
|
|
2023
Q3 | $513K | Buy |
27,598
+8,105
| +42% | +$151K | 0.44% | 63 |
|
|
2023
Q2 | $494K | Buy |
19,493
+100
| +0.5% | +$2.53K | 0.39% | 53 |
|
|
2023
Q1 | $502K | Buy |
19,393
+2,276
| +13% | +$58.9K | 0.35% | 61 |
|
|
2022
Q4 | $405K | Sell |
17,117
-4,300
| -20% | -$102K | 0.28% | 68 |
|
|
2022
Q3 | $543K | Sell |
21,417
-800
| -4% | -$20.3K | 0.36% | 63 |
|
|
2022
Q2 | $738K | Buy |
22,217
+896
| +4% | +$29.8K | 0.47% | 53 |
|
|
2022
Q1 | $1.54M | Buy |
21,321
+9,594
| +82% | +$692K | 0.97% | 16 |
|
|
2021
Q4 | $1.08M | Buy |
11,727
+3,850
| +49% | +$354K | 0.78% | 29 |
|
|
2021
Q3 | $999K | Buy |
7,877
+753
| +11% | +$95.5K | 0.73% | 36 |
|
|
2021
Q2 | $1.19M | Buy |
+7,124
| New | +$1.19M | 0.99% | 23 |
|
|
2020
Q4 | – | Sell |
-29
| Closed | -$6K | – | 398 |
|
|
2020
Q3 | $6K | Buy |
+29
| New | +$6K | ﹤0.01% | 350 |
|